Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy with beta-blocking-agents (author's transl)].

H D Bolte

    MMW, Munchener Medizinische Wochenschrift
    |November 3, 1978
    PubMed
    Summary

    Beta-blocking agents are now indicated for various conditions including heart disease and hypertension. Newer agents offer improved effects, but careful dosing is crucial due to individual sensitivities and potential side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Determinants of short-period heart rate variability in the general population.

    Cardiology·2001
    Same author

    [Temporal trends in myocardial infarct morbidity, mortality and 28-day fatalities and medical management. Results of the Augsburg Myocardial Infarct Register 1985 to 1992].

    Zeitschrift fur Kardiologie·1995
    Same author

    [Thrombolysis therapy and coronary angiography in acute myocardial infarct in the Augsburg region: results of the Augsburger Heart infarct register 1985-1987].

    Zeitschrift fur Kardiologie·1990
    Same author

    [Clinical aspects and conservative therapy of coronary heart disease in chronic renal failure].

    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin·1989
    Same author

    [The myocardial infarct status of a South German population: results of the Augsburg myocardial infarct register l985].

    Zeitschrift fur Kardiologie·1988
    Same author

    Morbidity and mortality of myocardial infarction in the MONICA study area Augsburg in 1985.

    Sozial- und Praventivmedizin·1988

    Area of Science:

    • Cardiology
    • Pharmacology

    Context:

    • Beta-blocking agents have evolved significantly in the last decade.
    • Indications have expanded beyond traditional cardiovascular uses.

    Purpose:

    • To outline current therapeutic regimens for beta-blocking agents.
    • To highlight advancements in beta-blocker development and their implications.

    Summary:

    • Updated indications include coronary heart disease, hypertension, hyperkinetic heart syndrome, thyrotoxicosis, arrhythmias, and neurologic-psychiatric conditions.
    • Newer beta-blocking agents exhibit distinct pharmacokinetic profiles, such as extended-release formulations (e.g., Tenormin), and enhanced cardioselectivity.
    • Therapeutic recommendations must be tailored to specific underlying diseases, acknowledging significant individual variations in drug sensitivity.
    • Initiating treatment with a careful, low-dose titration is essential to manage potential side effects.

    Impact:

    • Provides a framework for optimizing beta-blocker therapy based on disease-specific needs.
    • Emphasizes the importance of personalized medicine in beta-blocker treatment.
    • Informs clinicians about the evolving landscape of beta-blocking agents and their clinical application.

    Related Experiment Videos